Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S29 pseudogene 15 (RPS29P15) is a processed, non-functional copy of the RPS29 gene, which encodes a component of the small 40S ribosomal subunit essential for protein synthesis in cells[1][3][7]. As a pseudogene, RPS29P15 does not produce a functional protein and has no direct biological function, disease association, or known pharmacological relevance. Multiple pseudogenes for ribosomal proteins exist throughout the genome, but they are typically considered genomic relics without therapeutic or biomarker significance. The parent gene, RPS29, is important in ribosome structure and has roles in hematopoiesis and tumor suppression[1][2][3]. Mutations in RPS29 can cause Diamond–Blackfan anemia. However, pseudogenes like RPS29P15 do not encode proteins and therefore lack therapeutic, biomarker, or pharmacological utility[1][2][7]. In summary, RPS29P15 is a genomic pseudogene, not a functional protein nor a drug target. If the intention was RPS29 (the parent gene/protein), clarification would be needed; otherwise, this molecule/receptor is not suitable for structured therapeutic profiling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S29 pseudogene 15 (RPS29P15).